1. 28PCNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations. (7th November 2019) Authors: Papaccio, F; Valiente, F G; Gutierrez-Bravo, M F; Cabeza-Segura, M; Gambardella, V; Huerta, M D S; Martinez-Ciarpaglini, C; Alfaro-Cervello, C; Rentero-Garrido, P; Zúñiga-Trejos, S; Rosello Keranen, S; Fleitas, T; Tarazona, N; Roda Perez, D; Cervantes, A; Castillo, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 53PZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition. (7th November 2019) Authors: Valiente, F G; Tarazona, N; Gambardella, V; Riffo-Campos, Á; Papaccio, F; Cabeza-Segura, M; López-Rodas, G; Cervantes, A; Franco, L; Castillo, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 665PNRF2 activation via PI3K/AKT/mTOR/RPS6 causes resistance to anti-HER2 agents among HER2 amplified gastric cancer. (23rd October 2018) Authors: Gambardella, V; Gimeno-Valiente, F; Tarazona, N; Fleitas Kanonnikoff, T; Tolosa, P; Belda Moscardò, M; Garcia-Mico, B; Huerta, M; Roselló, S; Roda, D; Cervantes, A; Castillo, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Liquid biopsy: another tool towards tailored therapy in colorectal cancer. (10th October 2017) Authors: Tarazona, N; Cervantes, A Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer. (28th September 2019) Authors: Tarazona, N; Gimeno-Valiente, F; Gambardella, V; Zuñiga, S; Rentero-Garrido, P; Huerta, M; Roselló, S; Martinez-Ciarpaglini, C; Carbonell-Asins, J A; Carrasco, F; Ferrer-Martínez, A; Bruixola, G; Fleitas, T; Martín, J; Tébar-Martínez, R; Moro, D; Castillo, J; Espí, A; Roda, D; Cervantes, A Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Towards precision oncology for HER2 blockade in gastroesophageal adenocarcinoma. (2nd May 2019) Authors: Gambardella, V; Fleitas, T; Tarazona, N; Cejalvo, J M; Gimeno-Valiente, F; Martinez-Ciarpaglini, C; Huerta, M; Roselló, S; Castillo, J; Roda, D; Cervantes, A Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗